International – WHO publishes guidance for HPV vaccine developers to help tackle cervical cancer

Currently the main cause of cervical cancer – the fourth most common cancer in women globally – HPV is a very common group of...

International – ICH announces forthcoming documents on nitrosamine impurities, RWD

The International Council for Harmonisation (ICH) announced plans to issue two new documents: an addendum to the M7 guideline on assessing carcinogenic risk that...

International – ICH adopts M12 guideline on drug interaction studies, releases draft M14 guidance...

The International Council for Harmonisation (ICH) has adopted its M12 guidance, which promotes a harmonized approach in conducting and interpreting enzyme- or transporter-mediated in vitro and...
L’OMS adopte une résolution sur la transparence du marché des médicaments

International – WHO recommends risk management plans for high-risk excipients

The World Health Organization (WHO) has released two draft appendices to a recent draft guideline on good manufacturing practices (GMPs) for excipients. The first...
WHO drafts guidance for pharma supply chain tracking

International – WHO issues guidance on nitrosamine controls in drug manufacturing

The World Health Organization (WHO) released draft guidance for comment this month on good manufacturing practices (GMP) for the prevention and control of contamination...

International – ICH M13A BE testing guideline expected to be adopted this summer

The International Council for Harmonisation (ICH) is expected to adopt its M13A guideline on bioequivalence (BE) testing of immediate-release (IR) solid oral dosage form...

International – ICH E2D(R1) Guideline on post-approval safety data: definitions and standards for management...

It is important to establish an internationally standardised procedure to ensure the quality of post approval safety information and to harmonise, where feasible, the...

International – ICH Q12 IWG “Regulatory and Technical Considerations for Pharmaceutical Product Lifecycle Management »

L'ICH Q12 (IWG) "Regulatory and Technical Considerations for Pharmaceutical Product Lifecycle Management" Module 8 Training Material est désormais accessible sur le site web de...

International – ICH targets cell and gene therapies, real-world data as topics ripe for...

Officials from Health Canada and the pharmaceutical industry addressed plans to develop harmonized guidelines on cell and gene therapies and on the design of...

International – ICH consults on revised post-approval safety guideline that accounts for digital platforms

The International Council for Harmonisation (ICH) recently announced that its new draft E2D(R1) guideline on post-approval data and individual case safety reports (ICSRs) has...

NOS PROCHAINES FORMATIONS